UPDATED 7:10 AM PT — Tuesday, May 14, 2019
Kentucky’s attorney general is suing three top insulin manufacturers over their high prices. On Monday, Andy Beshear announced the lawsuit in a Kentucky state court against drug manufacturers Eli Lilly, Sanofi-Aventis, and Novo Nordisk for increasing their prices.
The lawsuit states all three companies have raised the cost of insulin at least 10 times since 2008, with the average price being $300 per vial.
According to Beshear, low-income residents who either lack insurance or pay high deductibles suffer the most from the price increases.
“These costs are driven by the high and inflated costs of prescription drugs. Many Kentuckians have to chose and make choices that they should never have to make. Deciding whether to get their prescription or keep their lights on. Whether to put food on the table, pay their power bill, or get that necessary medicine they deserve to live. No on should have to make those decisions.”
— Andy Beshear, attorney general- Ky.
The Kentucky lawmaker also claimed all three companies in the lawsuit own 96-percent of the insulin market. Over 15-percent of Kentucky residents suffer from diabetes.